Warby Parker Inc (WRBY)
23.11
-0.16
(-0.69%)
USD |
NYSE |
Nov 22, 16:00
23.09
-0.02
(-0.09%)
After-Hours: 20:00
Warby Parker Cash from Investing (Quarterly): -14.22M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -14.22M |
| June 30, 2024 | -17.65M |
| March 31, 2024 | -16.44M |
| December 31, 2023 | -13.57M |
| September 30, 2023 | -16.49M |
| June 30, 2023 | -12.22M |
| March 31, 2023 | -12.38M |
| December 31, 2022 | -14.22M |
| Date | Value |
|---|---|
| September 30, 2022 | -14.10M |
| June 30, 2022 | -15.81M |
| March 31, 2022 | -16.06M |
| December 31, 2021 | -14.50M |
| September 30, 2021 | -12.80M |
| June 30, 2021 | -12.53M |
| March 31, 2021 | -8.686M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-17.65M
Minimum
Jun 2024
-8.686M
Maximum
Mar 2021
-14.11M
Average
-14.22M
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| AptarGroup Inc | -80.67M |
| Daxor Corp | -- |
| Sanara MedTech Inc | -6.357M |
| Precision Optics Corp Inc | -0.0281M |
| Perspective Therapeutics Inc | -29.74M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 27.28M |
| Cash from Financing (Quarterly) | 0.047M |
| Free Cash Flow | 32.61M |
| Free Cash Flow Per Share (Quarterly) | 0.108 |
| Free Cash Flow to Equity (Quarterly) | 13.06M |
| Free Cash Flow to Firm (Quarterly) | 13.06M |
| Free Cash Flow Yield | 1.18% |